Table I.
Detailed data on patients prior to hepatic irreversible electroporation.
| Characteristic | n (%) |
|---|---|
| Sex | |
| Female | 9 (31.03) |
| Male | 20 (69.97) |
| HCC | 22 (75.9) |
| Sex (male/female) | 15/7 |
| Median age (years) | 52 |
| AJCC stage (2010) (37,38) | |
| IIIA | 2 (9.09) |
| IIIB | 1 (4.55) |
| IIIC | 2 (9.09) |
| IVA | 17 (77.27) |
| Hepatitis B positive | 7 (24.1) |
| Child-Pugh stage (15) | |
| A | 14 (63.64) |
| B | 8 (36.36) |
| Liver function | |
| ALT, U/l | 27±11 |
| AST, U/l | 44±43 |
| T.BIL, µmol/l | 18±7 |
| D.BIL, µmol/l | 7±4 |
| Tumor type | |
| Single massive | 17 (77.27) |
| Multinodular | 5 (22.73) |
| Ascites | |
| Yes | 14 (63.64) |
| No | 8 (36.36) |
| Pancreatic cancer with liver metastasis | 7 (24.1) |
| Sex (male/female) | 5/2 |
| Median age (years) | 53 |
| AJCC stage (24,38) | |
| III | 0 |
| IV | 7 |
| Liver function | |
| ALT, U/l | 35±11 |
| AST, U/l | 49±23 |
| T.BIL, µmol/l | 14±4 |
| D.BIL, µmol/l | 7±4 |
AJCC, American Joint Committee on Cancer staging system; HCC, hepatocellular carcinoma; ALT, alanine aminotransferase; AST aspartate aminotransferase; T.BIL, total bilirubin; D.BIL, direct bilirubin.